Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CRESANTO
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | | | | | | | | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | -20.0 | |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -100.0 | 60.0 | 0.0 | 0.0 | 37.5 | 0.0 | 0.0 | -1,150.0 | 240.0 | -350.0 | 50.0 | 64.0 |
| | | | | | | | | | | -20.0 | |
| -0.2 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | -0.6 | 0.2 | -0.2 | 0.0 | -0.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | | | | | | | | | | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | | -1,080.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 62.9 | -105.4 | -33.0 | -13.3 | 5.5 | -4.0 | -23.6 | -19.2 | -108.3 | 40.6 | -77.7 | 33.5 |
| | | | | | | | | | | | -240.0 |
| 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | 0.0 | -0.4 | -0.2 | -0.4 | -0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -7 | -7 | -7 | -7 |
Current Liabilities Current LiabilitiesCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| 166.1 | -14.3 | -0.2 | -0.5 | -2.1 | 0.5 | -0.5 | 2,689.1 | 95.8 | 59.7 | 262.9 |
CFO To EBITDA CFO To EBITDA% | 76.1 | -21.2 | -0.3 | -0.8 | -3.8 | 0.4 | -0.4 | 2,870.0 | 88.1 | 62.7 | 80.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | | | | | | | | | | | |
Price To Book Price To Book | -1.0 | -0.8 | -0.6 | -0.5 | -0.5 | -0.2 | -0.2 | -0.3 | -0.4 | -0.4 | -0.5 |
| -93.8 | -131.5 | -98.0 | -90.1 | -100.0 | -39.4 | -37.6 | -9.4 | -4.7 | -34.7 | -6.3 |
Profitability Ratios Profitability Ratios |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| -6.9 | -17.2 | -23.7 | -34.7 | -44.6 | -65.2 | -42.9 | 3.9 | 7.4 | -421.6 | 30.3 |
| 1.1 | 2.1 | 2.8 | 3.0 | 2.8 | 2.8 | 3.4 | 3.8 | 7.4 | 4.2 | 7.0 |
| -6.0 | -13.4 | -18.1 | -21.0 | -20.2 | -21.7 | -27.4 | -33.3 | -109.9 | -67.4 | -578.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Cresanto Global Limited is an Indian listed entity currently undergoing a foundational **strategic pivot** and **capital restructuring**. Following a change in ownership and management in early **2025**, the company is transitioning from a dormant pharmaceutical-focused business into a specialized **packaging and trading** enterprise. The company is currently executing a "clean-slate" strategy to address historical losses and position itself within the high-growth global flexible packaging market.
---
### **Strategic Pivot: From Pharmaceuticals to Flexible Packaging**
Following the approval of a new **Object Clause** in **May 2025**, the company has abandoned its legacy pharmaceutical mandate to focus on the manufacturing, trading, and distribution of packaging materials.
* **Core Business Activities:**
* **Manufacturing & Processing:** Production of packaging solutions using **paper, plastic, foils, and man-made fibers**.
* **Specialized Packaging:** Development of cardboard, corrugated, pillow, and polythene packing, as well as industrial containers and hollow wares.
* **Value-Added Services:** Specialized decoration and printing on paper sheets for food, commercial, and industrial applications.
* **Trading & Distribution:** Acting as a broker, importer, and exporter for **FMCG products**, plastic goods, and industrial spares.
* **Operational Philosophy:** The new model emphasizes a "customer-first" approach, integrating supply-chain reliability with a commitment to **eco-friendly materials** and sustainable trading practices.
---
### **Corporate Restructuring & New Management Control**
The company concluded a management takeover via an **Open Offer** in early **2025**, bringing in a new promoter group with a mandate for revitalization.
| Feature | Details |
| :--- | :--- |
| **New Promoter Group** | Nishant Nathmal Bajaj, Prashant Nathmal Bajaj, Hitesh Bajoria, Tushar Pandit Awante, and Urmila Hansraj Sharma |
| **Acquisition Stake (SPA)** | **12,12,050 shares (28.36%)** acquired from the erstwhile promoter |
| **Open Offer Details** | **11,11,110 shares (26%)** at **₹3.00 per share**; Total consideration **₹33.33 Lakhs** |
| **Post-Transaction Holding** | Up to **58.27%** of Voting Share Capital (assuming full acceptance) |
| **Key Leadership** | **Mr. Prashant Bajaj** appointed as **Managing Director & CFO** (5-year term) |
| **Board Composition** | **6 Directors** (1 Executive, 2 Independent, 3 Non-Executive) |
To align with this new identity, the company rebranded from **Raymed Labs Limited** to **Cresanto Global Limited** in **April 2025** and is relocating its registered office from **Uttar Pradesh** to **Mumbai, Maharashtra** to enhance operational efficiency.
---
### **Financial Reconstruction & Capital Reduction Scheme**
As of **March 31, 2025**, the company reported a turnaround in activity with revenue of **₹52.59 Lakhs**, a significant improvement over the zero-revenue status of **FY 2023-24**. However, to address **accumulated losses of ₹6.86 Crores**, the Board has approved a drastic **90% Capital Reduction**.
#### **Capital Reduction Table**
| Particulars | Pre-Reduction | Post-Reduction | Net Change |
| :--- | :--- | :--- | :--- |
| **Equity Share Capital** | **₹4,27,35,000** | **₹42,73,500** | **(₹3,84,61,500)** |
| **Total Equity Shares** | **4,273,500** | **427,350** | **(3,846,150)** |
| **Face Value per Share** | **₹10** | **₹10** | - |
| **Accumulated Losses** | **(₹6,86,14,000)** | **(₹3,01,52,500)** | **₹3,84,61,500** |
* **Rationale:** The reduction writes off **₹3.84 Crores** in losses against paid-up capital. This "leaner" balance sheet is intended to reflect actual asset values and enable future dividend payments and fund-raising.
* **Liquidity & Debt:** Total borrowings stand at **₹237.12 Lakhs**, all with a maturity of **1 to 5 years**. The company has not accepted public deposits.
---
### **Market Opportunity: The Flexible Packaging Sector**
Cresanto Global is entering a market projected to grow at a **CAGR of 5.8%** through **2034**.
* **Growth Drivers:**
* Surging demand for lightweight, cost-effective packaging in the **FMCG** and **Food & Beverage** sectors.
* The expansion of **e-commerce** requiring durable, specialized shipping materials.
* A global shift toward **recyclable and sustainable materials** to meet ESG mandates.
* **Competitive Landscape:** While the company pivots away from the pharmaceutical supply chain (where India holds a **20% global share**), it faces high pricing pressure from established packaging giants and volatility in raw material costs (plastics, films, and aluminum).
---
### **Listing Data & Shareholding Structure**
The company is listed on the **BSE** (Scrip Code: **531207**; Scrip ID: **RAYLA**).
| Category | Status / Value |
| :--- | :--- |
| **Trading Status** | Classified as **infrequently traded**; currently **suspended** due to past fee arrears |
| **Dematerialization** | **78.838%** (NSDL: 59.342%, CDSL: 19.496%) |
| **Physical Shares** | **21.162%** |
| **Listing Fees** | Outstanding interest dues of **₹1,62,250** for FY 2023-24 |
---
### **Critical Risk Factors & Auditor Concerns**
Investors should note several high-priority risks associated with this transition:
* **Going Concern Uncertainty:** Auditors have issued an **Emphasis of Matter** noting that the company’s net worth was substantially eroded and current liabilities exceeded current assets. Historically, administrative expenses were funded personally by a former Director due to a **paucity of funds**.
* **Transition Risk:** The company is moving from a period of **three years of total inactivity** into a highly competitive, capital-intensive packaging industry.
* **Regulatory Compliance:** The company has historically struggled with compliance, including the failure to appoint a **Whole Time Company Secretary** and delays in paying **Annual Listing Fees (ALF)** to the BSE.
* **Execution Risk:** The success of the pivot depends entirely on the new management's ability to deploy the **₹33.33 Lakh** escrow funds effectively and secure new contracts in the packaging space.
* **Asset Realizability:** While management claims **Current Assets and Loans** are realizable, historical debtor balances of **₹8.51 Lakh** were recently written off, indicating potential legacy asset quality issues.